Chandrasekar, T., Klaassen, Z., Goldberg, H., Sayyid, R. K., Kulkarni, G. S., & Fleshner, N. E. (2018). High competing risks minimize real-world utility of adjuvant targeted therapy in renal cell carcinoma: A population-based analysis. Oncotarget.
Styl ChicagoChandrasekar, Thenappan, Zachary Klaassen, Hanan Goldberg, Rashid K. Sayyid, Girish S. Kulkarni, a Neil E. Fleshner. "High Competing Risks Minimize Real-world Utility of Adjuvant Targeted Therapy in Renal Cell Carcinoma: A Population-based Analysis." Oncotarget 2018.
Citace podle MLAChandrasekar, Thenappan, et al. "High Competing Risks Minimize Real-world Utility of Adjuvant Targeted Therapy in Renal Cell Carcinoma: A Population-based Analysis." Oncotarget 2018.
Upozornění: Tyto citace jsou generovány automaticky. Nemusí být zcela správně podle citačních pravidel..